AQR CAPITAL MANAGEMENT LLC
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in SUPN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,078,901
-$1,194,727 QoQ
Shares Held
98,257
-22.2% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 97.96961030766256.ToString("F0")%
Shared 0.ToString("F0")%
None 2.0303896923374416.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. SUPN ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in SUPN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,078,901 | 98,257 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $6,273,628 | 126,230 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $6,519,843 | 136,427 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,430,355 | 140,557 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,791,084 | 85,224 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,279,597 | 63,042 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,864,905 | 59,811 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $373,269 | 13,954 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $468,500 | 13,735 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $504,279 | 17,425 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $366,570 | 13,296 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $320,078 | 10,648 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $381,791 | 10,538 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $408,171 | 11,443 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $278,043 | 8,214 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $224,014 | 7,746 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $237,016 | 8,887 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $234,101 | 8,942 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,215,907 | 48,327 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,410,888 | 67,701 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,988,706 | 83,735 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $806,131 | 44,810 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||